Long-term sacubitril/valsartan is well tolerated in dogs with heart failure and myxomatous mitral valve disease and suggests excellent survival benefits.
To determine the safety and survival data for dogs with congestive heart failure (CHF) and myxomatous mitral valve disease (MMVD) treated chronically with sacubitril/valsartan.